Related Experiment Videos
Characterisation using microphysiometry of CRF receptor pharmacology
D Smart1, A Coppell, C Rossant
1Parke-Davis Neuroscience Research Centre, Cambridge University Forvie Site, UK. darren_2_smart@sbphrd.com
European Journal of Pharmacology
|September 25, 1999
Summary
The Cytosensor microphysiometer effectively studies corticotropin-releasing factor (CRF) receptor pharmacology. This method accurately assesses CRF-receptor agonists and antagonists, validating its utility in receptor research.
Area of Science:
- Pharmacology
- Receptor Biology
- Biophysics
Background:
- Corticotropin-releasing factor (CRF) receptors are crucial in regulating stress responses.
- Understanding CRF receptor pharmacology is vital for developing targeted therapeutics.
- Existing methods for studying receptor activity can be limited in scope or throughput.
Purpose of the Study:
- To evaluate the Cytosensor microphysiometer for studying recombinant human CRF receptor pharmacology.
- To characterize the activity of various CRF receptor agonists and antagonists using this system.
- To confirm the Cytosensor's viability for functional assessment of CRF receptor ligands.
Main Methods:
- Chinese hamster ovary cells expressing human CRF1 or CRF2 receptors were utilized.
- Cells were perfused in a Cytosensor microphysiometer with a specialized Hams F12 medium.
- Agonist potency and antagonist affinity were determined through microphysiometry measurements.
Main Results:
- Distinct rank orders of agonist potency were observed for CRF1 (CRF=sauvagine=urocortin=urotensin) and CRF2 (urocortin>sauvagine>urotensin>CRF) receptors.
- alpha-Helical CRF (9-41) acted as a competitive antagonist at CRF2 and a partial agonist at CRF1.
- CP 154,526 demonstrated competitive antagonism at CRF1 but was inactive at CRF2.
Conclusions:
- The Cytosensor microphysiometer is a viable and effective tool for assessing CRF receptor pharmacology.
- The observed pharmacological profiles align with established knowledge of CRF receptor function.
- This method provides a robust platform for functional screening of CRF receptor modulators.